Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Silence Therapeutics (SLN) Shares Issued: 2020-2025

Historic Shares Issued for Silence Therapeutics (SLN) over the last 4 years, with Jun 2025 value amounting to $1,000.

  • Silence Therapeutics' Shares Issued fell 99.92% to $1,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $7.9 million, marking a year-over-year decrease of 95.13%. This contributed to the annual value of $142.1 million for FY2024, which is 344.90% up from last year.
  • Latest data reveals that Silence Therapeutics reported Shares Issued of $1,000 as of Q2 2025, which was down 92.86% from $14,000 recorded in Q1 2025.
  • Silence Therapeutics' Shares Issued's 5-year high stood at $133.0 million during Q1 2024, with a 5-year trough of -$1.4 million in Q1 2022.
  • For the 3-year period, Silence Therapeutics' Shares Issued averaged around $17.4 million, with its median value being $2.6 million (2023).
  • Examining YoY changes over the last 5 years, Silence Therapeutics' Shares Issued showed a top increase of 193,727.90% in 2022 and a maximum decrease of 103.37% in 2022.
  • Quarterly analysis of 5 years shows Silence Therapeutics' Shares Issued stood at $1,348 in 2021, then spiked by 10,515.44% to $143,097 in 2022, then surged by 7,955.07% to $11.5 million in 2023, then tumbled by 100.85% to -$98,000 in 2024, then slumped by 99.92% to $1,000 in 2025.
  • Its Shares Issued was $1,000 in Q2 2025, compared to $14,000 in Q1 2025 and -$98,000 in Q4 2024.